Abstract:<p>Prussian blue (PB) is an USA Food and Drug Administration (U.S. FDA)-approved antidote for the treatment of radioactive element poisoning such as thallium, which has been proved to have outstanding biosafety. Controllable morphology, size and structure of PB-based nanomaterials (PB NMs), and their excellent physicochemical properties, make them play an important role in the biomedical fields, such as drug delivery nano-systems, molecular imaging, and cancer treatment. In recent years, PB NMs have made great progress in cancer theranostics. Therefore, it is a great urgent to systematically summarize the recent progress to better serve the broad community of researchers. This review begins with the synthesis methods, regulatory approaches, and modification methods of PB NMs to achieve more uniform size and morphology. Next, according to the different properties of PB NMs, its application in the cancer theranostics has been gradually expanded, mainly including PB NMs for cancer imaging (single-modal and multi-modal imaging) and cancer therapy (monotherapy and combination therapy). For cancer imaging, single-modal imaging (e.g., photoacoustic (PA) imaging, ultrasound (US) imaging, magnetic resonance (MR) imaging), and multi-modal imaging based on PB NMs are systematically summarized, as well as strategies to improve the diagnostic effectiveness. For monotherapy, PB NMs are extensively used in photothermal therapy (PTT), sonodynamic therapy (SDT), and photodynamic therapy (PDT), owing to their excellent photothermal performance and unique physicochemical properties. Combined cancer therapy based on PB NMs to further enhance the cancer-killing efficiency is also systematically summarized. Moreover, the <em>in vivo</em> long-term toxicity of PB NMs is emphasized. Finally, the challenges, key factors, and the future prospects in the clinical transformation of PB NMs as multifunctional theranostic agents are simultaneously discussed. This review will provide reference and guidance for the design and application of PB NMs in the future bioapplications.</p>

Functionalization of bismuth sulfide nanomaterials for their application in cancer theranostics

How Do Bismuth-Based Nanomaterials Function as Promising Theranostic Agents for the Tumor Diagnosis and Therapy?

Application of bismuth sulfide based nanomaterials in cancer diagnosis and treatment

Recent developments in bismuth oxyhalide-based functional nanomaterials for biomedical applications

Bismuth-based two-dimensional nanomaterials for cancer diagnosis and treatment

Emerging Bismuth Chalcogenides Based Nanodrugs for Cancer Radiotherapy

Pnictogen Semimetal (sb, Bi)-Based Nanomaterials for Cancer Imaging and Therapy: A Materials Perspective

Application of Bismuth-Based Nanomaterials in Imaging Diagnosis and Therapy for Cancer

Tailoring Bismuth-Based Nanoparticles for Enhanced Radiosensitivity in Cancer Therapy

A biocompatible theranostic agent based on stable bismuth nanoparticles for X-ray computed tomography/magnetic resonance imaging-guided enhanced chemo/photothermal/chemodynamic therapy for tumours

Copper-based Nanomaterials for Cancer Theranostics

Recent advances in functional bismuth chalcogenide nanomaterials: Cancer theranostics, antibacterial and biosensing

Functionalized Cu3BiS3 Nanoparticles for Dual-Modal Imaging and Targeted Photothermal/photodynamic Therapy

Functional gadolinium-based nanoscale systems for cancer theranostics

Thiol-capped Bi Nanoparticles As Stable and All-in-one Type Theranostic Nanoagents for Tumor Imaging and Thermoradiotherapy.

Multifunctional Prussian blue-based nanomaterials: Preparation, modification, and theranostic applications

BSA‐Mediated Synthesis of Bismuth Sulfide Nanotheranostic Agents for Tumor Multimodal Imaging and Thermoradiotherapy

Ultrasmall Semimetal Nanoparticles of Bismuth for Dual-Modal Computed Tomography/Photoacoustic Imaging and Synergistic Thermoradiotherapy

Titanium-based nanomaterials for cancer theranostics

Multifunctional Nanostructured Materials for Multimodal Cancer Imaging and Therapy.

Inherent Multifunctional Inorganic Nanomaterials for Imaging-Guided Cancer Therapy